Aarti Surfactants Board of Directors

Get the latest insights into the leadership at Aarti Surfactants. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Mulesh Manilal Savla Chairman & Ind.Director
Mr. Nikhil Parimal Desai Managing Director & CEO
Mr. Santosh Madhaorao Kakade Whole Time Director
Mr. Chandrakant Vallabhaji Gogri Non Executive Director
Mr. Dattatray Sidram Galpalli Non Executive Director
Mrs. Misha Bharat Gala Independent Director

Aarti Surfactants Share price

AARTISURF

478

4.80 (-0.99%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:22 IST
BUYSELL
Today's High

494.95

Today's Low

470.00

52 Week Low

396.00

52 Week High

918.00

The current prices are delayed, login to your account for live prices

Aarti Surfactants FAQs

The board at Aarti Surfactants consists of experienced professionals, including Mr. Mulesh Manilal Savla , Mr. Nikhil Parimal Desai , and others, overseeing the company’s strategic and corporate governance.

Directors at Aarti Surfactants are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Mulesh Manilal Savla is the current chairman at Aarti Surfactants.

Executive directors at Aarti Surfactants are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Aarti Surfactants adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Aarti Surfactants, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.